基于中药血清药物化学的活性成分筛选的现状和问题  

Screening active ingredients based on serum pharmacochemistry of traditional Chinese medicine: current situation and problems

作　　者：黄财顺 向诚[1] 李宝才[1] 孔靓[1] 王怀基 

机构地区：[1]昆明理工大学生命科学与技术学院,云南昆明650500

出　　处：《中草药》2014年第20期3009-3014,共6页Chinese Traditional and Herbal Drugs

基　　金：国家自然科学基金资助项目(81403191;81460631);云南省科学研究基金资助项目(2013Y324);昆明理工大学药物代谢平台建设项目(14078184)

摘　　要：为了探讨基于中药血清药物化学的活性成分筛选的优势和存在问题,查阅了2003—2013年关于中药血清药物化学的研究文献,并进行统计分析。结果显示共涉及88个复方或单味药;共检测到血中移行成分970个,其中原型成分582个,代谢产物388个;鉴定结构的原型成分270个,占入血原型成分的46.4%;鉴定结构的代谢产物为37个,占代谢产物的9.53%;80.37%的被鉴定结构的原型成分有活性报道。基于中药血清药物化学的活性成分筛选有快速、准确、低成本、易操作、应用面广等优点,是一种高效的中药活性成分筛选方法。但该方法应用范围有一定的局限性,应用现状还存在研究不规范、不系统、不深入、国际和产业推广度低等问题。In order to evaluate the advantages and problems of serum pharmacochemistry of traditional Chinese medicine（TCM） for screening active ingredients, all literatures concerned from 2003 to 2013 were searched and analyzed. According to our statistics, there were 88 Chinese materia medica（CMM） formulae or single herbs involved; Nine hundred and seventy components were absorbed into blood, including 582 prototype components and 388 metabolites; Among them, 270 prototype components（46.4%） were identified, and only 37 metabolites（9.53%） were identified. Further investigation suggested that 80.37% of the absorbed prototype components identified were pharmacologically active according to relative reports. Thus, the above method is not only fast, accurate, and cost-saving, but also easy to operate, popularize, and utilize in most screening cases of CMM. However, this method has certain limitations at the range of application and problems such as non-standard, non-system, no indepth, low internationalization or industry promotion.

关 键 词：中药血清药物化学 活性成分筛选 原型成分 代谢产物 中药复方 

分 类 号：R284[医药卫生—中药学]